Sales Slowed But Not That Much
Though cannabis sales have slowed across the country, even in monster markets like Michigan and Illinois, most agree that the drop has to do with oversupply, which has forced retailers to slash prices and, again, they’re all facing competition from the unlicensed market.
But let’s be positive as we look at the top cannabis stocks in these three categories: best value, fastest growth and best stock performance.
Curaleaf Holdings also had a decent Q4 2022 with net revenue of $1.336 billion, a 12% increase compared to $1.195 billion in FY 2021. In addition to operating in 19 states with 152 dispensaries, there’s also Curaleaf International which is the largest vertically integrated cannabis company in Europe with its own supply and distribution network in EU.
Cannabis Stocks: Don't Be Shy
Despite the, at times, disappointing performance of weed stocks over the past year, let's not forget what MJBizDaily and other analysts have been saying: U.S. cannabis sales are projected to surpass $33 billion in 2023 and up to $57 billion by the end of 2028.
So, yeah, not a bad place to invest some money.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
